bpc-157 human safety evidence clinical trials review regulatory status Gastric pentadecapeptide body protection compound BPC BPC-157 FDA Approval Status: Is
Description
Recently, the FDA released updated 503A and 503B interim bulks lists
Furthermore, they can be harvested easily from autologous and allogeneic sources
GiorgioVMieleLPrincipessaLFerrettiFVillaMPNegroVet al
The core move here is not, trust clinicians who say these work. The core move is, we understand the Agencys balancing test, and we have tried to close the exact gaps the Agency identified. Whether FDA agrees is a separate issue
